NeuroSync
PrivateLast Round
Early Funding
May 17, 2023
Total Funding Raised
$39.6M
Company Overview
NeuroSync is a digital health company that provides an AI-powered platform for assessing brain health, delivering therapy, and optimizing cognitive performance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, AR/VR Hardware, Defense Tech, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSync Comparables
Compare NeuroSync with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oculogica | 87% | |
| RightEye | 84% | |
| EyeGuide, Inc. | 82% | |
NeuroSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 17, 2023 | ||||
| Series A | Jan 3, 2018 | ||||
| Accelerator | Jun 13, 2017 |
NeuroSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quadrant Management | Series A |
| U.S. Department of War | Grant |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2023
$15M raised in early funding.
- Jun 13, 2017
$100K round from MassChallenge
NeuroSync Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroSync's valuation, stock price, and market status.